CN Stock MarketDetailed Quotes

002462 Cachet Pharmaceutical

Watchlist
  • 12.70
  • +0.01+0.08%
Market Closed Apr 30 15:00 CST
3.70BMarket Cap14.37P/E (TTM)

Cachet Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
10.17%7.44B
14.40%30B
7.43%21.79B
17.09%14.88B
4.57%6.76B
2.32%26.22B
4.81%20.28B
1.15%12.71B
11.19%6.46B
10.19%25.63B
Operating revenue
10.17%7.44B
14.40%30B
7.43%21.79B
17.09%14.88B
4.57%6.76B
2.32%26.22B
4.81%20.28B
1.15%12.71B
11.19%6.46B
10.19%25.63B
Other operating revenue
----
--0
----
-4.54%89.77M
----
--0
----
54.54%94.04M
----
--0
Total operating cost
10.22%7.29B
14.81%29.27B
7.64%21.25B
17.27%14.52B
4.96%6.61B
2.88%25.49B
5.36%19.74B
1.79%12.38B
11.79%6.3B
11.34%24.78B
Operating cost
11.73%7.02B
16.20%28.02B
8.00%20.27B
18.49%13.85B
5.65%6.29B
2.67%24.11B
5.77%18.77B
1.49%11.69B
12.15%5.95B
11.19%23.48B
Operating tax surcharges
13.43%11.09M
11.79%51.2M
7.95%38.13M
6.60%24.77M
4.95%9.78M
2.38%45.8M
9.38%35.32M
17.88%23.24M
13.69%9.32M
11.08%44.73M
Operating expense
-23.83%149.24M
-13.17%724.91M
5.67%593.1M
-4.57%402.55M
-11.67%195.92M
4.31%834.82M
-10.18%561.28M
3.48%421.81M
3.04%221.8M
17.90%800.31M
Administration expense
-7.80%74.4M
2.51%326.6M
-3.46%228.21M
2.04%156.3M
5.30%80.69M
10.68%318.61M
13.60%236.39M
17.34%153.18M
16.82%76.63M
21.75%287.87M
Financial expense
-23.13%32.01M
-19.61%143.87M
-12.52%115.55M
-9.44%79.99M
-2.69%41.64M
12.62%178.97M
8.17%132.08M
4.81%88.33M
0.67%42.79M
-9.91%158.91M
-Interest expense (Financial expense)
----
-11.35%155.42M
----
----
----
14.76%175.31M
----
----
----
-10.58%152.75M
-Interest Income (Financial expense)
----
-38.75%-31.12M
----
----
----
-31.01%-22.43M
----
----
----
15.08%-17.12M
Research and development
----
----
----
----
----
----
--2.72M
--1.78M
--863.22K
----
Credit Impairment Loss
21.50%-13.26M
-13.71%-104.47M
-5.24%-53.51M
-106.70%-47.13M
-110.96%-16.89M
-235.36%-91.88M
-274.70%-50.85M
-1,971.28%-22.8M
-149.30%-8M
53.25%-27.4M
Asset Impairment Loss
356.89%3.87M
-316.20%-98.3M
-258.06%-27.6M
-223.01%-20.77M
-172.50%-1.51M
-8.82%-23.62M
5.31%17.46M
23.09%16.88M
--2.08M
83.62%-21.7M
Other net revenue
71.20%-2.49M
-120.50%-174.78M
-6,262.89%-59.62M
-387.22%-49.72M
-207.79%-8.64M
-336.38%-79.26M
-103.27%-936.96K
-49.74%17.31M
-68.68%8.02M
89.77%-18.16M
Fair value change income
381.82%23.13K
61.80%-25.36K
73.44%-25.36K
70.00%-15.67K
60.42%-8.21K
87.12%-66.39K
---95.49K
---52.22K
---20.73K
---515.49K
Invest income
201.28%239.8K
-35.19%-3.47M
-471.21%-617.52K
-447.96%-496.9K
---236.77K
-266.81%-2.57M
--166.35K
---90.68K
----
115.72%1.54M
-Including: Investment income associates
----
82.47%92.16K
----
----
----
-32.94%50.51K
----
----
----
129.23%75.31K
Asset deal income
1,305.81%201.59K
-49.40%845.56K
31.33%592.01K
574.60%211.57K
-159.93%-16.72K
126.15%1.67M
41.04%450.79K
-93.06%31.36K
-92.11%27.9K
-42.23%738.9K
Other revenue
-35.72%6.44M
-17.60%30.65M
-32.51%21.55M
-20.85%18.48M
-28.15%10.01M
27.50%37.2M
26.25%31.92M
22.50%23.34M
54.77%13.94M
31.93%29.17M
Operating profit
12.90%150.51M
-14.42%556.36M
-11.07%482.77M
-9.60%311.64M
-20.24%133.32M
-21.75%650.1M
-16.01%542.89M
-20.81%344.73M
-16.13%167.15M
0.72%830.77M
Add:Non operating Income
3,437.83%11.57M
126.70%2.62M
42.30%1.49M
221.19%1.31M
29.78%327.01K
22.72%1.16M
79.80%1.05M
194.77%408.98K
-94.58%251.97K
-20.22%941.48K
Less:Non operating expense
-32.43%502.81K
-41.71%3.7M
-64.64%1.74M
-35.85%1.39M
94.71%744.08K
-17.87%6.35M
-10.21%4.92M
-53.96%2.17M
-79.66%382.15K
-33.73%7.73M
Total profit
21.58%161.58M
-13.90%555.28M
-10.48%482.53M
-9.16%311.56M
-20.43%132.9M
-21.73%644.91M
-15.97%539.02M
-20.38%342.97M
-17.34%167.02M
1.19%823.98M
Less:Income tax cost
25.27%44.22M
1.22%178.75M
-12.10%122.83M
-8.10%79.96M
-22.62%35.3M
-20.49%176.59M
-19.91%139.74M
-27.21%87M
-20.20%45.62M
-0.58%222.1M
Net profit
20.24%117.35M
-19.60%376.53M
-9.91%359.69M
-9.52%231.6M
-19.61%97.6M
-22.19%468.31M
-14.50%399.27M
-17.76%255.97M
-16.21%121.4M
1.86%601.88M
Net profit from continuing operation
20.24%117.35M
-19.60%376.53M
-9.91%359.69M
-9.52%231.6M
-19.61%97.6M
-22.19%468.31M
-14.50%399.27M
-17.76%255.97M
-16.21%121.4M
1.86%601.88M
Less:Minority Profit
40.04%41.82M
-26.20%126.47M
-19.27%122.83M
-11.99%76.11M
-29.83%29.86M
-30.90%171.38M
-24.45%152.15M
-36.45%86.48M
-32.51%42.56M
-9.26%248M
Net profit of parent company owners
11.51%75.53M
-15.79%250.06M
-4.15%236.86M
-8.26%155.49M
-14.08%67.73M
-16.09%296.94M
-6.96%247.12M
-3.24%169.49M
-3.65%78.84M
11.43%353.88M
Earning per share
Basic earning per share
11.50%0.2589
-15.69%0.86
-4.71%0.81
-8.62%0.53
-14.00%0.2322
-15.70%1.02
-6.59%0.85
-3.33%0.58
-3.57%0.27
11.01%1.21
Diluted earning per share
11.50%0.2589
-15.69%0.86
-4.71%0.81
-8.62%0.53
-14.00%0.2322
-15.70%1.02
-6.59%0.85
-3.33%0.58
-3.57%0.27
11.01%1.21
Other composite income
Total composite income
20.24%117.35M
-19.60%376.53M
-9.91%359.69M
-9.52%231.6M
-19.61%97.6M
-22.19%468.31M
-14.50%399.27M
-17.76%255.97M
-16.21%121.4M
1.86%601.88M
Total composite income of parent company owners
11.51%75.53M
-15.79%250.06M
-4.15%236.86M
-8.26%155.49M
-14.08%67.73M
-16.09%296.94M
-6.96%247.12M
-3.24%169.49M
-3.65%78.84M
11.43%353.88M
Total composite income of minority owners
40.04%41.82M
-26.20%126.47M
-19.27%122.83M
-11.99%76.11M
-29.83%29.86M
-30.90%171.38M
-24.45%152.15M
-36.45%86.48M
-32.51%42.56M
-9.26%248M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 10.17%7.44B14.40%30B7.43%21.79B17.09%14.88B4.57%6.76B2.32%26.22B4.81%20.28B1.15%12.71B11.19%6.46B10.19%25.63B
Operating revenue 10.17%7.44B14.40%30B7.43%21.79B17.09%14.88B4.57%6.76B2.32%26.22B4.81%20.28B1.15%12.71B11.19%6.46B10.19%25.63B
Other operating revenue ------0-----4.54%89.77M------0----54.54%94.04M------0
Total operating cost 10.22%7.29B14.81%29.27B7.64%21.25B17.27%14.52B4.96%6.61B2.88%25.49B5.36%19.74B1.79%12.38B11.79%6.3B11.34%24.78B
Operating cost 11.73%7.02B16.20%28.02B8.00%20.27B18.49%13.85B5.65%6.29B2.67%24.11B5.77%18.77B1.49%11.69B12.15%5.95B11.19%23.48B
Operating tax surcharges 13.43%11.09M11.79%51.2M7.95%38.13M6.60%24.77M4.95%9.78M2.38%45.8M9.38%35.32M17.88%23.24M13.69%9.32M11.08%44.73M
Operating expense -23.83%149.24M-13.17%724.91M5.67%593.1M-4.57%402.55M-11.67%195.92M4.31%834.82M-10.18%561.28M3.48%421.81M3.04%221.8M17.90%800.31M
Administration expense -7.80%74.4M2.51%326.6M-3.46%228.21M2.04%156.3M5.30%80.69M10.68%318.61M13.60%236.39M17.34%153.18M16.82%76.63M21.75%287.87M
Financial expense -23.13%32.01M-19.61%143.87M-12.52%115.55M-9.44%79.99M-2.69%41.64M12.62%178.97M8.17%132.08M4.81%88.33M0.67%42.79M-9.91%158.91M
-Interest expense (Financial expense) -----11.35%155.42M------------14.76%175.31M-------------10.58%152.75M
-Interest Income (Financial expense) -----38.75%-31.12M-------------31.01%-22.43M------------15.08%-17.12M
Research and development --------------------------2.72M--1.78M--863.22K----
Credit Impairment Loss 21.50%-13.26M-13.71%-104.47M-5.24%-53.51M-106.70%-47.13M-110.96%-16.89M-235.36%-91.88M-274.70%-50.85M-1,971.28%-22.8M-149.30%-8M53.25%-27.4M
Asset Impairment Loss 356.89%3.87M-316.20%-98.3M-258.06%-27.6M-223.01%-20.77M-172.50%-1.51M-8.82%-23.62M5.31%17.46M23.09%16.88M--2.08M83.62%-21.7M
Other net revenue 71.20%-2.49M-120.50%-174.78M-6,262.89%-59.62M-387.22%-49.72M-207.79%-8.64M-336.38%-79.26M-103.27%-936.96K-49.74%17.31M-68.68%8.02M89.77%-18.16M
Fair value change income 381.82%23.13K61.80%-25.36K73.44%-25.36K70.00%-15.67K60.42%-8.21K87.12%-66.39K---95.49K---52.22K---20.73K---515.49K
Invest income 201.28%239.8K-35.19%-3.47M-471.21%-617.52K-447.96%-496.9K---236.77K-266.81%-2.57M--166.35K---90.68K----115.72%1.54M
-Including: Investment income associates ----82.47%92.16K-------------32.94%50.51K------------129.23%75.31K
Asset deal income 1,305.81%201.59K-49.40%845.56K31.33%592.01K574.60%211.57K-159.93%-16.72K126.15%1.67M41.04%450.79K-93.06%31.36K-92.11%27.9K-42.23%738.9K
Other revenue -35.72%6.44M-17.60%30.65M-32.51%21.55M-20.85%18.48M-28.15%10.01M27.50%37.2M26.25%31.92M22.50%23.34M54.77%13.94M31.93%29.17M
Operating profit 12.90%150.51M-14.42%556.36M-11.07%482.77M-9.60%311.64M-20.24%133.32M-21.75%650.1M-16.01%542.89M-20.81%344.73M-16.13%167.15M0.72%830.77M
Add:Non operating Income 3,437.83%11.57M126.70%2.62M42.30%1.49M221.19%1.31M29.78%327.01K22.72%1.16M79.80%1.05M194.77%408.98K-94.58%251.97K-20.22%941.48K
Less:Non operating expense -32.43%502.81K-41.71%3.7M-64.64%1.74M-35.85%1.39M94.71%744.08K-17.87%6.35M-10.21%4.92M-53.96%2.17M-79.66%382.15K-33.73%7.73M
Total profit 21.58%161.58M-13.90%555.28M-10.48%482.53M-9.16%311.56M-20.43%132.9M-21.73%644.91M-15.97%539.02M-20.38%342.97M-17.34%167.02M1.19%823.98M
Less:Income tax cost 25.27%44.22M1.22%178.75M-12.10%122.83M-8.10%79.96M-22.62%35.3M-20.49%176.59M-19.91%139.74M-27.21%87M-20.20%45.62M-0.58%222.1M
Net profit 20.24%117.35M-19.60%376.53M-9.91%359.69M-9.52%231.6M-19.61%97.6M-22.19%468.31M-14.50%399.27M-17.76%255.97M-16.21%121.4M1.86%601.88M
Net profit from continuing operation 20.24%117.35M-19.60%376.53M-9.91%359.69M-9.52%231.6M-19.61%97.6M-22.19%468.31M-14.50%399.27M-17.76%255.97M-16.21%121.4M1.86%601.88M
Less:Minority Profit 40.04%41.82M-26.20%126.47M-19.27%122.83M-11.99%76.11M-29.83%29.86M-30.90%171.38M-24.45%152.15M-36.45%86.48M-32.51%42.56M-9.26%248M
Net profit of parent company owners 11.51%75.53M-15.79%250.06M-4.15%236.86M-8.26%155.49M-14.08%67.73M-16.09%296.94M-6.96%247.12M-3.24%169.49M-3.65%78.84M11.43%353.88M
Earning per share
Basic earning per share 11.50%0.2589-15.69%0.86-4.71%0.81-8.62%0.53-14.00%0.2322-15.70%1.02-6.59%0.85-3.33%0.58-3.57%0.2711.01%1.21
Diluted earning per share 11.50%0.2589-15.69%0.86-4.71%0.81-8.62%0.53-14.00%0.2322-15.70%1.02-6.59%0.85-3.33%0.58-3.57%0.2711.01%1.21
Other composite income
Total composite income 20.24%117.35M-19.60%376.53M-9.91%359.69M-9.52%231.6M-19.61%97.6M-22.19%468.31M-14.50%399.27M-17.76%255.97M-16.21%121.4M1.86%601.88M
Total composite income of parent company owners 11.51%75.53M-15.79%250.06M-4.15%236.86M-8.26%155.49M-14.08%67.73M-16.09%296.94M-6.96%247.12M-3.24%169.49M-3.65%78.84M11.43%353.88M
Total composite income of minority owners 40.04%41.82M-26.20%126.47M-19.27%122.83M-11.99%76.11M-29.83%29.86M-30.90%171.38M-24.45%152.15M-36.45%86.48M-32.51%42.56M-9.26%248M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg